Protein-based tumor biomarker predicts breast-cancer survival

The first and largest clinical trial of its kind confirms that a protein called p27 may be a valuable tool for predicting survival after a diagnosis of breast cancer.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news84560230.html">Protein-based tumor biomarker predicts breast-cancer survival</a></p> <p>The first and largest clinical trial of its kind confirms that a protein called p27 may be a valuable tool for predicting survival after a diagnosis of breast cancer. </p>